State Street’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-807,443
Closed -$1.49M 4810
2023
Q1
$1.49M Buy
807,443
+159,134
+25% +$294K ﹤0.01% 3423
2022
Q4
$720K Sell
648,309
-4,726
-0.7% -$5.25K ﹤0.01% 3643
2022
Q3
$1.53M Sell
653,035
-4,884
-0.7% -$11.4K ﹤0.01% 3487
2022
Q2
$1.99M Buy
657,919
+126,890
+24% +$384K ﹤0.01% 3480
2022
Q1
$3.61M Buy
531,029
+24,271
+5% +$165K ﹤0.01% 3332
2021
Q4
$4.23M Buy
506,758
+8,773
+2% +$73.2K ﹤0.01% 3315
2021
Q3
$3.7M Buy
497,985
+59,220
+13% +$440K ﹤0.01% 3391
2021
Q2
$2.98M Buy
438,765
+132,486
+43% +$901K ﹤0.01% 3468
2021
Q1
$3.15M Sell
306,279
-22,427
-7% -$230K ﹤0.01% 3250
2020
Q4
$2.3M Sell
328,706
-6,840
-2% -$47.9K ﹤0.01% 3308
2020
Q3
$2.74M Sell
335,546
-20,170
-6% -$165K ﹤0.01% 3071
2020
Q2
$2.45M Sell
355,716
-63,056
-15% -$435K ﹤0.01% 3096
2020
Q1
$1.99M Buy
418,772
+10,081
+2% +$47.9K ﹤0.01% 3074
2019
Q4
$3.57M Sell
408,691
-11,986
-3% -$105K ﹤0.01% 3012
2019
Q3
$1.4M Buy
420,677
+46,608
+12% +$155K ﹤0.01% 3328
2019
Q2
$1.85M Buy
374,069
+120,174
+47% +$595K ﹤0.01% 3268
2019
Q1
$1.57M Buy
253,895
+13,016
+5% +$80.7K ﹤0.01% 3234
2018
Q4
$812K Sell
240,879
-20,110
-8% -$67.8K ﹤0.01% 3365
2018
Q3
$1.7M Buy
260,989
+5,312
+2% +$34.6K ﹤0.01% 3306
2018
Q2
$1.96M Buy
255,677
+2,298
+0.9% +$17.6K ﹤0.01% 3270
2018
Q1
$5.66M Buy
253,379
+71,219
+39% +$1.59M ﹤0.01% 2737
2017
Q4
$2.32M Buy
182,160
+28,122
+18% +$359K ﹤0.01% 3130
2017
Q3
$2.4M Buy
154,038
+53,805
+54% +$838K ﹤0.01% 3122
2017
Q2
$1.41M Buy
100,233
+54,803
+121% +$770K ﹤0.01% 3255
2017
Q1
$1M Buy
+45,430
New +$1M ﹤0.01% 3261